adalimumab

Infliximab vs Adalimumab: Which Is Best for Behçet Syndrome?

Medscape - 07 Nov 2024
Infliximab vs Adalimumab: Which Is Best for Behçet Syndrome? ...

Biosimilar medicine fact sheet – adalimumab

Department of Health - 22 Oct 2024
Biosimilar medicine fact sheet – adalimumab ...

Adalimumab-Associated Depressive Symptoms in VAIHS

The Journal of Clinical Psychiatry - 29 Aug 2024
Adalimumab-Associated Depressive Symptoms in VAIHS ...

The impact of EU public procurement regulations on tenders in Spain: a study with adalimumab

Frontiers - 18 Sep 2024
The impact of EU public procurement regulations on tenders in Spain: a study with adalimumab ...

Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine

Healio - 21 Oct 2024
Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine ...

Effect of adalimumab on choroidal thickness and choroidal vascularity index in eyes with non-infectious uveitis using enhanced-depth imaging optical coherence tomography

Nature.com - 20 Feb 2024
Effect of adalimumab on choroidal thickness and choroidal vascularity index in eyes with non-infectious uveitis using enhanced-depth imaging optical coherence tomography ...

Updated: FDA Approves Aucatzyl for Adults with Aggressive Leukemia

Managed Healthcare Executive - 08 Nov 2024
Updated: FDA Approves Aucatzyl for Adults with Aggressive Leukemia ...

When Patients Develop Antibodies to TNF Inhibitors

MedCentral - 08 Apr 2024
When Patients Develop Antibodies to TNF Inhibitors ...

Baseline ANA and Anti-Ro60/SSA Antibody as Potential Predictors for Immunogenicity and Poor EULAR Response in Adalimumab-Treated RA Patients

Wiley Online Library - 26 Aug 2024
Baseline ANA and Anti-Ro60/SSA Antibody as Potential Predictors for Immunogenicity and Poor EULAR Response in Adalimumab-Treated RA Patients ...

Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series

Journal of Ophthalmic Inflammation and Infection - 30 Jul 2024
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series ...

Despite Projections of a 2024 Adalimumab Biosimilar Boom,

GlobeNewswire - 23 Sep 2024
Despite Projections of a 2024 Adalimumab Biosimilar Boom, ...

Competitive Pricing in Biosimilars: How Adalimumab Could Shape the Industry

The Center for Biosimilars - 29 Oct 2024
Competitive Pricing in Biosimilars: How Adalimumab Could Shape the Industry ...

Adalimumab Market 2024: Industry Growth and Future Scope

openPR - 11 Nov 2024
Adalimumab Market 2024: Industry Growth and Future Scope ...

Copay Assistance Programs for Adalimumab Biosimilars

MD Magazine - 03 May 2024
Copay Assistance Programs for Adalimumab Biosimilars ...

Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse

Medscape - 19 Sep 2024
Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse ...

Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial

Frontiers - 27 Jun 2024
Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial ...